Detalhe da pesquisa
1.
Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungals.
J Antimicrob Chemother
; 75(1): 221-228, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31580432
2.
Short-term risk of liver and renal injury in hospitalized patients using micafungin: a multicentre cohort study.
J Antimicrob Chemother
; 71(10): 2938-44, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27407049